Financial Calendar

2022

Date

Event

28 September

Unaudited Results to 30 June 2022

31 March

Admission to trading and first day of dealings

Latest RNS News

04 January 2023

Commercial and scientific update

28 September 2022

Unaudited Results to 30 June 2022

14 September 2022

New commercialisation partner in Asia Pacific

Latest Interview

ProBiotix Health anticipating "big commercial opportunities" during 2023
Group CEO Stephen O’Hara and CEO Steen Anderson | 04 January 2023
www.proactiveinvestors.co.uk

Investor Alert